PI3K/Akt/mTOR and MAPK/ERK Pathway Activation In research settings, IGF-1 LR3 activates the PI3K/Akt pathway (involved in survival, glucose metabolism, and protein synthesis), the RAS/MAPK pathway (regulating growth and differentiation), the mTOR pathway (governing anabolic protein synthesis signalling), and IRS-1/2 cross-talk with insulin receptor signalling the full complement of IGF-1R-mediated downstream effects
effective but less selective, with greater cortisol and prolactin effects
All of the five therapeutic GLP-1RAs, currently approved for therapy of type 2 diabetes, are peptide molecules, which are administered in subcutaneous injections
These hypotheses were tested clinically
This slowing of digestion is part of what helps control appetite, but it can also cause mild nausea or discomfort as your body adapts
Injectable forms show faster results but they don't last, which is why maintenance is part of the deal